Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 632

1.

Important New Fragrance Allergens. II. Limonene Hydroperoxides.

de Groot A.

Dermatitis. 2019 Aug 19. doi: 10.1097/DER.0000000000000465. [Epub ahead of print]

PMID:
31433385
2.

Contact Allergy to and Other Adverse Effects of Fragrances: A Brief Overview.

de Groot AC.

Dermatitis. 2019 Aug 19. doi: 10.1097/DER.0000000000000463. [Epub ahead of print]

PMID:
31433384
3.

Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models.

Hoffmann PR, Hoffmann FW, Premeaux TA, Fujita T, Soprana E, Panigada M, Chew GM, Richard G, Hindocha P, Menor M, Khadka VS, Deng Y, Moise L, Ndhlovu LC, Siccardi A, Weinberg AD, De Groot AS, Bertino P.

Front Oncol. 2019 Aug 2;9:720. doi: 10.3389/fonc.2019.00720. eCollection 2019.

4.

Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.

Scholzen A, Richard G, Moise L, Hartman E, Bleeker-Rovers CP, Reeves PM, Raju Paul S, Martin WD, De Groot AS, Poznansky MC, Sluder AE, Garritsen A.

Infect Immun. 2019 Sep 19;87(10). pii: e00213-19. doi: 10.1128/IAI.00213-19. Print 2019 Oct.

PMID:
31331958
5.

Highly conserved influenza T cell epitopes induce broadly protective immunity.

Eickhoff CS, Terry FE, Peng L, Meza KA, Sakala IG, Van Aartsen D, Moise L, Martin WD, Schriewer J, Buller RM, De Groot AS, Hoft DF.

Vaccine. 2019 Aug 23;37(36):5371-5381. doi: 10.1016/j.vaccine.2019.07.033. Epub 2019 Jul 19.

PMID:
31331771
6.

Linalool Hydroperoxides.

de Groot A.

Dermatitis. 2019 Jul/Aug;30(4):243-246. doi: 10.1097/DER.0000000000000471.

PMID:
31313746
7.

A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.

Hewitt JS, Karuppannan AK, Tan S, Gauger P, Halbur PG, Gerber PF, De Groot AS, Moise L, Opriessnig T.

Vaccine. 2019 Jul 18;37(31):4302-4309. doi: 10.1016/j.vaccine.2019.06.044. Epub 2019 Jun 24.

PMID:
31248687
8.

Equity in maternal health outcomes in a middle-income urban setting: a cohort study.

De Groot A, Van de Munt L, Boateng D, Savitri AI, Antwi E, Bolten N, Klipstein-Grobusch K, Uiterwaal CSPM, Browne JL.

Reprod Health. 2019 Jun 18;16(1):84. doi: 10.1186/s12978-019-0736-3.

9.

Adding sorbitan sesquioleate to the European baseline series: Necessary, reasonable, or unavoidable?

de Groot A, Gilissen L, Geier J, Orton D, Goossens A.

Contact Dermatitis. 2019 Sep;81(3):221-225. doi: 10.1111/cod.13332. Epub 2019 Jun 27.

PMID:
31177535
10.

Four Years of CHEER: Cost and QALY Savings of a Free Nurse-run Walk-in Clinic Serving an Uninsured, Predominantly Spanish-speaking Immigrant Population in Providence.

Barry K, McCarthy M, Buckley J, Jacques S, Johnson H, Almeida-Monroe V, De Groot AS.

J Health Care Poor Underserved. 2019;30(2):806-819. doi: 10.1353/hpu.2019.0057.

PMID:
31130552
11.

WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.

Caron P, Pankotai T, Wiegant WW, Tollenaere MAX, Furst A, Bonhomme C, Helfricht A, de Groot A, Pastink A, Vertegaal ACO, Luijsterburg MS, Soutoglou E, van Attikum H.

Genes Dev. 2019 Jun 1;33(11-12):684-704. doi: 10.1101/gad.321943.118. Epub 2019 May 2.

12.

Higher ER load is not associated with better outcome in stage 1-3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer.

Noordhoek I, de Groot AF, Cohen D, Liefers GJ, Portielje JEA, Kroep JR.

Breast Cancer Res Treat. 2019 Jul;176(1):27-36. doi: 10.1007/s10549-019-05233-9. Epub 2019 Apr 17. Review.

13.

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.

de Groot AF, Blok EJ, Charehbili A, Engels CC, Smit VTHBM, Dekker-Ensink NG, Putter H, Meershoek-Klein Kranenbarg E, van de Velde CJH, Liefers GJ, Nortier JWR, Kuppen PJK, van der Burg SH, Kroep JR.

Breast Cancer Res Treat. 2019 Jun;175(3):605-615. doi: 10.1007/s10549-019-05195-y. Epub 2019 Mar 13.

14.
15.

Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.

Scholzen A, Richard G, Moise L, Baeten LA, Reeves PM, Martin WD, Brauns TA, Boyle CM, Raju Paul S, Bucala R, Bowen RA, Garritsen A, De Groot AS, Sluder AE, Poznansky MC.

Front Immunol. 2019 Feb 15;10:207. doi: 10.3389/fimmu.2019.00207. eCollection 2019.

16.

Design of a multiepitopic Zaire ebolavirus protein and its expression in plant cells.

Nieto-Gómez R, Angulo C, Monreal-Escalante E, Govea-Alonso DO, De Groot AS, Rosales-Mendoza S.

J Biotechnol. 2019 Apr 10;295:41-48. doi: 10.1016/j.jbiotec.2019.02.003. Epub 2019 Feb 28.

PMID:
30826446
17.

HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA).

De Groot AS, Kazi ZB, Martin RF, Terry FE, Desai AK, Martin WD, Kishnani PS.

Clin Immunol. 2019 Mar;200:66-70. doi: 10.1016/j.clim.2019.01.009. Epub 2019 Jan 31.

18.

Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi.

Khan S, Parrillo M, Gutierrez AH, Terry FE, Moise L, Martin WD, De Groot AS.

Hum Vaccin Immunother. 2019 Jan 7:1-14. doi: 10.1080/21645515.2018.1560772. [Epub ahead of print]

PMID:
30614773
19.

Community clinic-based lifestyle change for prevention of metabolic syndrome: Rationale, design and methods of the 'Vida Sana/healthy life' program.

Risica PM, McCarthy M, Barry K, Oliverio SP, De Groot AS.

Contemp Clin Trials Commun. 2018 Oct 25;12:123-128. doi: 10.1016/j.conctc.2018.10.002. eCollection 2018 Dec.

20.

Bridging the [Health Equity] Gap at a Free Clinic for Uninsured Residents of Rhode Island.

Hindocha P, Nair NJ, Pigoga JL, Barry K, McCarthy M, Almeida-Monroe V, De Groot AS.

R I Med J (2013). 2018 Nov 1;101(9):27-31.

PMID:
30384516
21.

Conservation and diversity of radiation and oxidative stress resistance mechanisms in Deinococcus species.

Lim S, Jung JH, Blanchard L, de Groot A.

FEMS Microbiol Rev. 2019 Jan 1;43(1):19-52. doi: 10.1093/femsre/fuy037. Review.

22.

The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival.

Santegoets SJAM, de Groot AF, Dijkgraaf EM, Simões AMC, van der Noord VE, van Ham JJ, Welters MJP, Kroep JR, van der Burg SH.

Oncoimmunology. 2018 May 31;7(8):e1465166. doi: 10.1080/2162402X.2018.1465166. eCollection 2018.

23.

T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response.

Moise L, M Biron B, Boyle CM, Kurt Yilmaz N, Jang H, Schiffer C, M Ross T, Martin WD, De Groot AS.

Hum Vaccin Immunother. 2018;14(9):2203-2207. doi: 10.1080/21645515.2018.1495303. Epub 2018 Sep 5. Review.

24.

Human iPSC-derived neuronal models for in vitro neurotoxicity assessment.

Tukker AM, Wijnolts FMJ, de Groot A, Westerink RHS.

Neurotoxicology. 2018 Jul;67:215-225. doi: 10.1016/j.neuro.2018.06.007. Epub 2018 Jun 19.

25.

Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design.

de Groot AM, Thanki K, Gangloff M, Falkenberg E, Zeng X, van Bijnen DCJ, van Eden W, Franzyk H, Nielsen HM, Broere F, Gay NJ, Foged C, Sijts AJAM.

Mol Ther Nucleic Acids. 2018 Jun 1;11:159-169. doi: 10.1016/j.omtn.2018.02.003. Epub 2018 Feb 13.

26.

Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages.

de Groot AE, Pienta KJ.

Oncotarget. 2018 Feb 21;9(29):20908-20927. doi: 10.18632/oncotarget.24556. eCollection 2018 Apr 17. Review.

27.

Ten unanswered questions in cancer: "If this is true, what does it imply"?

Amend SR, de Groot AE, Torga G, Axelrod HD, Reyes DK, Valkenburg KC, Glavaris SA, Pienta KJ.

Am J Clin Exp Urol. 2018 Apr 1;6(2):26-31. eCollection 2018. No abstract available.

28.

Targeting the tumour stroma to improve cancer therapy.

Valkenburg KC, de Groot AE, Pienta KJ.

Nat Rev Clin Oncol. 2018 Jun;15(6):366-381. doi: 10.1038/s41571-018-0007-1. Review.

29.

Community-based childhood obesity prevention intervention for parents improves health behaviors and food parenting practices among Hispanic, low-income parents.

Otterbach L, Mena NZ, Greene G, Redding CA, De Groot A, Tovar A.

BMC Obes. 2018 Mar 27;5:11. doi: 10.1186/s40608-018-0188-2. eCollection 2018.

30.

Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ.

Hrdinová J, Verbij FC, Kaijen PHP, Hartholt RB, van Alphen F, Lardy N, Ten Brinke A, Vanhoorelbeke K, Hindocha PJ, De Groot AS, Meijer AB, Voorberg J, Peyron I.

Haematologica. 2018 Jun;103(6):1083-1092. doi: 10.3324/haematol.2017.179119. Epub 2018 Mar 22.

31.

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid.

de Groot AM, Platteel ACM, Kuijt N, van Kooten PJS, Vos PJ, Sijts AJAM, van der Maaden K.

Front Immunol. 2017 Dec 13;8:1789. doi: 10.3389/fimmu.2017.01789. eCollection 2017.

32.

[Comprehensive geriatric care for frail elderly at home: a feasibility study].

Kroes J, van Buul L, Veenhuizen R, de Groot A, Depla M, Vergeer W, Hertogh C.

Tijdschr Gerontol Geriatr. 2018 Apr;49(2):81-89. doi: 10.1007/s12439-017-0242-4. Dutch.

PMID:
29188478
33.

The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review.

de Groot AF, Appelman-Dijkstra NM, van der Burg SH, Kroep JR.

Cancer Treat Rev. 2018 Jan;62:18-28. doi: 10.1016/j.ctrv.2017.10.010. Epub 2017 Nov 2. Review.

34.

Contact Allergy to Neem Oil.

de Groot A, Jagtman BA, Woutersen M.

Dermatitis. 2017 Nov/Dec;28(6):360-362. doi: 10.1097/DER.0000000000000309.

PMID:
29059091
35.

T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin.

Gutiérrez AH, Rapp-Gabrielson VJ, Terry FE, Loving CL, Moise L, Martin WD, De Groot AS.

Influenza Other Respir Viruses. 2017 Nov;11(6):531-542. doi: 10.1111/irv.12513.

36.

CDK4/6 inhibition in early and metastatic breast cancer: A review.

de Groot AF, Kuijpers CJ, Kroep JR.

Cancer Treat Rev. 2017 Nov;60:130-138. doi: 10.1016/j.ctrv.2017.09.003. Epub 2017 Sep 20. Review.

PMID:
28961554
37.

Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacterium.

de Groot AM, Du G, Mönkäre J, Platteel ACM, Broere F, Bouwstra JA, Sijts AJAM.

J Control Release. 2017 Nov 28;266:27-35. doi: 10.1016/j.jconrel.2017.09.017. Epub 2017 Sep 14.

38.

Cathelicidins Inhibit Escherichia coli-Induced TLR2 and TLR4 Activation in a Viability-Dependent Manner.

Coorens M, Schneider VAF, de Groot AM, van Dijk A, Meijerink M, Wells JM, Scheenstra MR, Veldhuizen EJA, Haagsman HP.

J Immunol. 2017 Aug 15;199(4):1418-1428. doi: 10.4049/jimmunol.1602164. Epub 2017 Jul 14.

39.

Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening Approaches.

Rombouts FJR, Alexander R, Cleiren E, De Groot A, Carpentier M, Dijkmans J, Fierens K, Masure S, Moechars D, Palomino-Schätzlein M, Pineda-Lucena A, Trabanco AA, Van Glabbeek D, Vos A, Tresadern G.

ACS Omega. 2017 Feb 28;2(2):685-697. doi: 10.1021/acsomega.6b00482. Epub 2017 Feb 24.

40.

An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.

Bounds CE, Terry FE, Moise L, Hannaman D, Martin WD, De Groot AS, Suschak JJ, Dupuy LC, Schmaljohn CS.

Hum Vaccin Immunother. 2017 Dec 2;13(12):2824-2836. doi: 10.1080/21645515.2017.1329788. Epub 2017 Jun 2.

41.

Conservation and diversity of the IrrE/DdrO-controlled radiation response in radiation-resistant Deinococcus bacteria.

Blanchard L, Guérin P, Roche D, Cruveiller S, Pignol D, Vallenet D, Armengaud J, de Groot A.

Microbiologyopen. 2017 Aug;6(4). doi: 10.1002/mbo3.477. Epub 2017 Apr 11.

42.

The Influence of Activity-Based Funding on Treatment Intensity and Length of Stay of Geriatric Rehabilitation Patients.

Bouwstra H, Wattel LM, de Groot AJ, Smalbrugge M, Hertogh CM.

J Am Med Dir Assoc. 2017 Jun 1;18(6):549.e15-549.e22. doi: 10.1016/j.jamda.2017.02.003. Epub 2017 Apr 1.

PMID:
28377154
43.

Synthesis and evaluation of novel HCV replication inhibitors.

McGowan DC, Khamlichi MD, De Groot A, Pauwels F, Delouvroy F, Van Emelen K, Simmen K, Raboisson P.

Mol Divers. 2017 May;21(2):475-481. doi: 10.1007/s11030-017-9733-z. Epub 2017 Mar 14.

PMID:
28293834
44.

Contact Allergy to (Ingredients of) Toothpastes.

de Groot A.

Dermatitis. 2017 Mar/Apr;28(2):95-114. doi: 10.1097/DER.0000000000000255. Review.

PMID:
28291073
45.

Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.

Téguété I, Dolo A, Sangare K, Sissoko A, Rochas M, Beseme S, Tounkara K, Yekta S, De Groot AS, Koita OA.

PLoS One. 2017 Feb 23;12(2):e0172661. doi: 10.1371/journal.pone.0172661. eCollection 2017.

46.

Revisiting Seed and Soil: Examining the Primary Tumor and Cancer Cell Foraging in Metastasis.

de Groot AE, Roy S, Brown JS, Pienta KJ, Amend SR.

Mol Cancer Res. 2017 Apr;15(4):361-370. doi: 10.1158/1541-7786.MCR-16-0436. Epub 2017 Feb 16. Review.

47.

Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali.

De Groot AS, Tounkara K, Rochas M, Beseme S, Yekta S, Diallo FS, Tracy JK, Teguete I, Koita OA.

PLoS One. 2017 Feb 13;12(2):e0171631. doi: 10.1371/journal.pone.0171631. eCollection 2017.

48.

De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy.

Mufarrege EF, Giorgetti S, Etcheverrigaray M, Terry F, Martin W, De Groot AS.

Clin Immunol. 2017 Mar;176:31-41. doi: 10.1016/j.clim.2017.01.003. Epub 2017 Jan 10.

PMID:
28089609
49.

The Role of Patient Navigators in Building a Medical Home for Multiply Diagnosed HIV-Positive Homeless Populations.

Sarango M, de Groot A, Hirschi M, Umeh CA, Rajabiun S.

J Public Health Manag Pract. 2017 May/Jun;23(3):276-282. doi: 10.1097/PHH.0000000000000512.

50.

Innovation, urgency and acceptance at the 9th Vaccine Renaissance.

De Groot AS, Moise L.

Hum Vaccin Immunother. 2016 Dec;12(12):3186-3188. doi: 10.1080/21645515.2016.1254853. No abstract available.

Supplemental Content

Loading ...
Support Center